Cell and Tissue Culture Supplies Market by Product (Media, Sera, Reagents, Vessels and Accessories)
Industry: Healthcare
Published Date: February-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 250
Report ID: PMRREP3221
The Global revenue from the Cell Tissue Culture Supplies Market was approximately US$ 13.0 Billion in 2022, with the global market expected to grow at a CAGR of 11.2% to reach a valuation of approximately US$ 41.3 Billion by the end of 2033.
|
Market Size (2023) |
US$ 14.3 Billion |
|
Projected Market Value (2033) |
US$ 41.3 Billion |
|
Global Market Growth Rate (2023 to 2033) |
11.2% CAGR |
|
Market Share of Top 5 Countries |
60.2% |
As assessed by Persistence Market Research, the product segment media held a market share of around 33.54% in the global market, in 2022. Overall, cell tissue culture supplies market sales account for approximately 51.1% of revenue share in the global cell culture media market, which was valued at around US$ 25.4 Billion in 2022.
The global market recorded a historic CAGR of 8.7% in the last 8 years from 2014 to 2022.
The market for cell culture media is expanding at a large rate owing to the biopharmaceutical sector's ongoing expansion and the rise in the number of new and innovative medication proposals entering clinical trials. The capabilities and capacity of the contract manufacturing organizations (CMOs) are growing. The manufacture of biopharmaceuticals is rising as awareness of their potential to cure chronic diseases grows.
Despite downstream operations are frequently seen as the biopharmaceutical industry's bottleneck, they are increasingly using serum-free media for cell culture growth. The advent of modern manufacturing technology, ongoing improvement in manufacturing scalability, and alternative downstream processes are some of the main factors contributing to an increase in biopharmaceutical production.
With the capital funding, scientists are concentrating more on drug development. Different culture mediums have been used to cultivate human cell lines, providing useful information on how the cells work.
The market for cell and tissue culture supplies is also expanding significantly on a global scale because of rising research and development in the field of cell and tissue engineering, expanding uses for cell and tissue culture, and rising rates of chronic illness prevalence. The development of sophisticated cell culture products, the rising need for monoclonal for single-use technologies and the increasing emphasis on individualized treatment are the main factors driving this market's rise.
On the other hand, the high cost of cell biology research puts a constraint on the growth of this company. Cell culture technology that is based on culture media has proven to be a dependable, efficient, and still-developing method.
Frequently, immune systems produce antibodies. Numerous synthetic antibodies have been created through in vitro research using a variety of cell lines. Monoclonal antibodies have been used to treat many auto-immune diseases. These monoclonal antibodies were produced using various cell culture media, which stimulated the growth of the cell culture media industry.
The field of tissue engineering has developed recently. Among the tissues that can be generated in a lab are blood vessels, ligaments, cartilage, and bones.
The global market is likely to show high growth over the coming years at a CAGR of 11.2% and reach a global market size of US$ 41.3 Billion by 2033.
“Emerging market players, regulatory oversight focus, and contract manufacturing introduction”
It is projected that the market would expand in the next years as a result of an increase in the manufacture of monoclonal antibodies using cell culture media.
The market for cell and tissue culture supplies is being driven by an increase in the need for biopharmaceuticals, artificial organs, and cell and tissue culture techniques. Also, the global market for cell and tissue culture supplies is being constrained by factors including stringent licensing and certification requirements and the complexity of cell culture techniques.
The loss of organs and tissues due to illness and damage is motivating the development of medications that can reduce transplantation by grafting tissue using cell culture media as a nutrition.
For the treatment of focal articular cartilage abnormalities, Cortical, the first FDA-approved biologic product in the orthopedic area, uses fetal bovine serum as a nutrition.
The demand for efficient and secure vaccinations is rising along with the prevalence of infectious illnesses. Compared to conventional approaches, cell culture-based vaccinations provide a variety of benefits, including increased efficacy and safety. As a result, there is a clearer understanding of the advantages of cell-based vaccines, which is fueling the expansion of the market for cell culture.
“Increasing concerns related to sterility of culture media”
One of the key things preventing the market's overall expansion is the massive cost of research and development operations. The cost of the tissue culture media increases because each ingredient, such as amino acids, proteins, and carbohydrates, must be added in a specific ratio. The lengthy method of creating cell culture media is anticipated to impede the market's overall growth. Also one of the main obstacles for the global cell culture industry is also the high cost of the research equipment used in cell biology. Which may limit their uptake by small and medium-sized businesses, impeding the expansion of the market for cell tissue culture supplies.
Preventing contamination of the tissue culture media is the main priority. There is a good risk that the medium containing several cell types will become contaminated. In vitro techniques have a high risk of chemical and microbiological contamination. Although it frequently happens in scientific settings, contamination can come from a wide range of substances.
Theunderstanding is required to avoid any cellular contamination of the culture material. The growth of the tissue culture market may be slowed by all of these factors.
Why is the United States Market Booming?
“Introduction of new-cost effective cell culture media”
The United States accounted for around 29.7% market share in the global market in 2022.
The availability of inexpensive cell culture media represents a big opportunity for the industry's growth. In the next years, market growth is anticipated to be fueled by the development of cost-effective cell culture medium due to the usage of novel manufacturing techniques for serum-free media.
One of the most recent changes in the global market for cell and tissue culture supplies has been the rise in interest in contract research as well as serum-free, specialized, and customized media solutions. Serum-free culture media is expected to be widely used in the United States since it is less expensive than media that contains serum.
Will the United Kingdom Be a Lucrative Market for Cell Tissue Culture Supplies?
“Rise in pharmaceutical sector and presence of strong market player”
The United Kingdom market held around 6.1% market share of the global market in 2022.
The United Kingdom market is profitable because of improvements in cell culture instruments, due to biotechnology and pharmaceutical businesses, as well as researchers and scientists in the area, have a significant need for cell culture supplies. Also, the expansion of new biopharmaceutical manufacturing facilities and increased investment in research and development could open up new business opportunities. The government and pharmaceutical firms are being encouraged by this to make significant investments in new drug research and development operations.
How is China Emerging as a Prominent Market?
“Increasing government funding for innovations in cell culture media”
China held a market share of about 11.9% of the global market in 2022.
One of the key factors driving the market for cell culture media in China has been the rise in government funding for research and development initiatives and various life science projects. An increase in global investments and money for research and development has given scientists numerous opportunities to develop novel culture media.
Which Product is Driving Demand within the Global Market?
“Higher product availability and increasing adoption”
The media product segment held around 33.54% share of the total market in 2022.
The media credited consistent performance, enhanced growth and output, improved control over physiological responsiveness, and decreased risk of contamination. It continues to hold a significant proportion during the projection period. The chemical or artificial media used in tissue culture is made up of specific inorganic compounds and inorganic salts. A variety of tissue culture and living cell types may also be present in the culture media for growth.
Which Application is Largely Adopted within the Global Market?
“Rising popularity of biopharmaceuticals among patients”
Biopharmaceutical production application held around 32.8% share of the total market in 2022.
The increasing use of cell cultures in the biopharmaceuticals has contributed to the industry's dominance in the manufacturing of biopharmaceuticals. Globally, there is a growing demand for non-conventional medications because of the bioproduction of genetically and proteomically modified pharmaceuticals. The need for cell culture techniques is increasing because of increased research and development in the biopharmaceutical industry.
In addition, the adoption of biopharmaceutical production has increased the demand for cell culture techniques among researchers and contract manufacturers.
Which End User Propels the Global Sales in the Market?
“The cell culture product sales remain concentrated in the pharma and biopharmaceutical companies”
The Pharma and biopharmaceutical companies held a share of about 63.34% in 2022, within the global market.
In parallel to the launch of novel therapies, the production of pharmaceuticals and biopharmaceuticals is rising thanks to the development of biosimilar, or generic biopharmaceuticals, which can be produced by a variety of businesses. With the development of culture technology and the rapid growth of the biopharmaceutical industry, the market for cell culture is anticipated to expand quickly.
In order to diversify their product offering and increase their market position, major market players are implementing strategic initiatives like mergers and acquisitions, expansion, and the development of new products. With the assistance of an informed market overview, opportunities, challenges, trends, size and growth, and competition analysis, the market report offers a thorough picture of the market.
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the cell tissue culture supplies market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2014 to 2022 |
|
Market Analysis |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Application:
End User:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at around US$ 13.0 Billion in 2022.
Sales of the market are set to witness growth at a CAGR of 11.2% and be valued at around US$ 41.3 Billion by 2033.
Demand for the global cell tissue culture supplies market increased at an 8.7% CAGR from 2014 – 2022.
The U.S., China, Germany, the U.K., and Japan account for most demand within the market, currently holding around 60.2% market share.
The U.S. accounts for around 29.7% share of the global market in 2022.
Latin America accounts for around 6.3% share of the global market in 2022.
The China market held a share of about 11.9% in the global cell tissue culture supplies market in 2022.
The German cell tissue culture supplies market accounts for 7.7% of the global market in 2022.
The North America cell tissue culture supplies market holds the share of 32.6% in 2022.
The cell tissue culture supplies market in Europe holds the share of 29.6% globally in 2022.
